Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0964020120120010058
Journal of the Korean Liver Cancer Study Group
2012 Volume.12 No. 1 p.58 ~ p.61
A Case of a Advanced Stage Hepatocelluar Carcinoma Patient with Relatively Good Response after Combination Therapy
Seock Chang-Hyeon

Lee Dan-Bi
Shim Ju-Hyun
Kim Kang-Mo
Lim Young-Suk
Lee Han-Chu
Chung Young-Hwa
Lee Yung-Sang
Abstract
According to AASLD practice guideline, for patients who present with advanced hepatocelluar carcinoma, new data indicates the efficacy of sorafenib in prolonging life. But there are no data comparing combination transarterial chemoemboliation with sorafenib to sorafenib treatment alone. We experienced a case that treated a patient with combination therapy including transarterial chemoembolization for intrahepatic hepatocelluarcarcinoma, radiation therapy for portal vein thrombosis and sorafenib treatment. He was in stable disease state after 6 months later. Therefore, it seems to be need to study for comparing combination therapy to sorafenib, or to transarterial chemoembolization.
KEYWORD
Hepatocellular carcinoma, Sorafenib, Advanced stage HCC
FullTexts / Linksout information
Listed journal information